Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: Controlled study with half-side comparison analysis

Photodermatology Photoimmunology and Photomedicine

Volumn 23, Issue 6, 2007, Pages 215-221

  Durand, F ^a   Staumont, D ^a   Bonnevalle, A ^a   Hachulla, E ^a   Hatron, P Y ^a   Thomas, Pier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acrosclerosis; Systemic sclerosis; UVA1 Phototherapy

Indexed keywords

ACROSCLEROSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HAND DISEASE; HAND MOVEMENT; HUMAN; MALE; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC SCLEROSIS; ULTRAVIOLET A RADIATION; ULTRAVIOLET A1 RADIATION; VISUAL ANALOG SCALE;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; ULTRAVIOLET THERAPY; WOUND HEALING;

EID: 35848962909     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2007.00308.x     Document Type: Article

References (22)

1. Blann AD, Illingworth K, Jayson MI. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325-1330.
2. Rose NR, Leskovsek N. Scleroderma: Immunopathogenesis and treatment. Immunol Today 1998; 19: 499-501.
3. Mauch C, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T. Control of fibrosis in systemic scleroderma. J Invest Dermatol 1993; 100: 92S-96S.
4. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-363.
5. Wahl SM, Wahl LM, McCarthy JB. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol 1978; 121: 942-946.
6. Roumm AD, Whiteside TL, Medsger TA Jr., Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 1984; 27: 645-653.
7. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768.
8. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
9. Petersen MJ, Hansen C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99: 440-444.
10. Wlaschek M, Briviba K, Stricklin GP, Sies H, Scharffetter-Kochanek K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol 1995; 104: 194-198.
11. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296.
12. Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: Effects on acrosclerosis. J Am Acad Dermatol 2004; 50: 740-747.
13. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
14. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
15. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36 (6 Pt 1): 938-944.
16. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-674.
17. von Kobyletzki G, Uhle A, Pieck C, Hoffmann K, Altmeyer P. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol 2000; 136: 275-276.
18. El-Mofty M, Mostafa W, El-Darouty M, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. A clinico-pathologic study. Photodermatol Photoimmunol Photomed 2004; 20: 148-156.
19. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979; 22: 130-140.
20. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-1896.
21. Khanna D, Furst DE, Clements PJ, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005; 32: 832-840.
22. Georges C, Chassany O, Mouthon L, et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 2005; 24: 3-10.